There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Innovative Eyewear, Inc. (LUCY – Research Report), Rockwell Med (RMTI – Research Report) and Mereo Biopharma Group Plc (MREO – Research Report) with bullish sentiments.
Innovative Eyewear, Inc. (LUCY)
In a report released yesterday, Matthew Galinko from Maxim Group maintained a Buy rating on Innovative Eyewear, Inc.. The company’s shares closed last Wednesday at $0.19, close to its 52-week low of $0.18.
According to TipRanks.com, Galinko has 0 stars on 0-5 stars ranking scale with an average return of
The the analyst consensus on Innovative Eyewear, Inc. is currently a Moderate Buy rating.
See Insiders’ Hot Stocks on TipRanks >>
Rockwell Med (RMTI)
Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Rockwell Med yesterday and set a price target of $5.00. The company’s shares closed last Wednesday at $1.71, close to its 52-week low of $1.16.
According to TipRanks.com, Vendetti is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Rockwell Med with a $7.00 average price target, a 319.2% upside from current levels. In a report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $9.00 price target.
Mereo Biopharma Group Plc (MREO)
In a report released today, Gil Blum from Needham maintained a Buy rating on Mereo Biopharma Group Plc, with a price target of $6.00. The company’s shares closed last Wednesday at $3.17.
According to TipRanks.com, Blum is a 3-star analyst with an average return of
Currently, the analyst consensus on Mereo Biopharma Group Plc is a Strong Buy with an average price target of $6.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on LUCY:
